Glycoprotein expression in ceacam1−/− mice
Glycoprotein . | MFI in wild-type mice (n = 3) . | MFI in ceacam1−/− mice (n = 3) . |
---|---|---|
GPVI | 87.9 ± 5.9 | 78.3 ± 9.8 |
Integrin αbβ3 | 254.7 ± 15.6 | 245.0 ± 16.5 |
GPIbα/IX/V complex | 242.6 ± 23.2 | 231.9 ± 29.4 |
Integrin α2β1 | 60.7 ± 1.9 | 51.9 ± 2.7 |
PECAM-1 | 39.9 ± 12.7 | 32.4 ± 10.1 |
CD9 | 258.2 ± 1.0 | 256.3 ± 43.7 |
CD44 | 134.7 ± 2.5 | 113.3 ± 10.8 |
CEACAM1 | 39.7 ± 1.4 | 3.8 ± 0.04 |
Glycoprotein . | MFI in wild-type mice (n = 3) . | MFI in ceacam1−/− mice (n = 3) . |
---|---|---|
GPVI | 87.9 ± 5.9 | 78.3 ± 9.8 |
Integrin αbβ3 | 254.7 ± 15.6 | 245.0 ± 16.5 |
GPIbα/IX/V complex | 242.6 ± 23.2 | 231.9 ± 29.4 |
Integrin α2β1 | 60.7 ± 1.9 | 51.9 ± 2.7 |
PECAM-1 | 39.9 ± 12.7 | 32.4 ± 10.1 |
CD9 | 258.2 ± 1.0 | 256.3 ± 43.7 |
CD44 | 134.7 ± 2.5 | 113.3 ± 10.8 |
CEACAM1 | 39.7 ± 1.4 | 3.8 ± 0.04 |
Cell surface expression of platelet glycoprotein expression was monitored by flow cytometry using specific monoclonal antibodies for wild-type and ceacam1−/− mice. MFIs are reported as mean plus or minus SEM for three independent experiments.